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We and others (8, 9, 31, 38) have shown that one mechanism that links hypoxic sensing with nitrite reduction to NO is a reaction with deoxyhemoglobin (reaction 1). This reaction is in contrast to nitrite oxidation to nitrate, which occurs upon reaction with oxyhemoglobin (reaction 2). The nitrite reductase activity of deoxyhemoglobin was shown to be regulated allosterically, exhibiting maximal kinetics around the hemoglobin O 2 tension at which hemoglobin is 50% deoxygenated (P 50 ) (9, 12, 20) . Evidence that NO produced from this reaction was competent to stimulate signaling was indicated by stimulation of vasodilation, increased vascular cGMP levels [the product of soluble guanylate cyclase (sGC) activation], and inhibition of mitochondrial respiration, which were all reversed by the NO scavenger 2-carboxyphenyl-4,4 -5,5-tetramethylimidazoline-1-oxyl-3-oxide (C-PTIO) (9) .
While the detailed mechanisms and biochemical intermediates that lead to NO generation from the reaction of deoxyhemoglobin and nitrite remain under investigation (24) , an interesting paradox arises given that both oxyhemoglobin and deoxyhemoglobin potently scavenge NO (reactions 3-4), raising the possibility that deoxyhemoglobin-dependent modula-tion of NO homeostasis will be determined by the balance between NO scavenging and NO generation from nitrite. (11) showed, under a constant contractile stimulus, that hypoxia alone sensitized aortic vascular preparations to nitrite such that the concentration of nitrite required to vasodilate was significantly lowered to close to the physiological range. Dalsgaard and colleagues also showed that nitrite-dependent dilation was cGMP dependent, indicating metabolism to NO. They concluded from these experiments that nitrite potently vasodilates aortic rings and that hemoglobin does not regulate this process. However, their experimental data clearly show that while oxyhemoglobin inhibited nitrite-dependent vasodilation, deoxyhemoglobin had no apparent inhibitory effect. Put more simply, they clearly observed a potent nitrite vasodilation in aortic rings alone at low O 2 , but in the presence of oxyhemoglobin this dilation was inhibited and in the presence of deoxyhemoglobin this dilation was preserved. This suggests a unique interaction between nitrite and deoxyhemoglobin in modulating NO-dependent vasodilation. Because nitrite-dependent dilation is proceeding via NO formation, both oxyhemoglobin and deoxyhemoglobin should inhibit the dilation equally, given the similar and rapid rates (ϳ10 7 M Ϫ1 ⅐ s Ϫ1 ) of NO scavenging (reactions 3-4), which are orders of magnitude higher than rates of reactions with nitrite (24) . Therefore, differences in NO scavenging or nitrite scavenging are unlikely to underlie the differential effects of oxyhemoglobin versus deoxyhemoglobin on nitritedependent vasodilation. We therefore hypothesized that oxyhemoglobin inhibits nitrite-dependent dilation due to NO scavenging, whereas deoxyhemoglobin does not produce apparent inhibition because its reactions with nitrite represent a balance of vasodilator (nitrite reductase) and vasoconstrictor (NO scavenging) activities. We tested this hypothesis by performing full factorial experiments measuring nitrite-and hemoglobin-dependent dilation of isolated aortic rings at different O 2 tensions. Importantly, we also compared these interactions with a direct NO donor and the NO-scavenger C-PTIO, which does not react with nitrite. These experiments confirm that the reactions between nitrite and hemoglobin in aortic ring bioassays at different hemoglobin fractional O 2 saturations exhibit a unique interaction: nitrite-dependent vasodilation is inhibited at high hemoglobin O 2 fractional saturation, whereas vasodilation is promoted when hemoglobin deoxygenates, supporting the hemoglobin nitrite reductase hypothesis of hypoxic vasodilation.
MATERIALS AND METHODS
Materials. All reagents were purchased from Sigma (St. Louis, MO) except for methylamine hexamethylene methylamine NONOate (MNO), which was purchased from Axxora Platform (San Diego, CA). Sodium nitrite was dissolved in PBS (pH 7.4). Indomethacin and C-PTIO were dissolved in 100% ethanol or methanol, respectively, which was diluted in vessel relaxation experiments to a final solvent concentration of 0.1% (vol/vol). No effects of these solvents were observed on vasoactive responses at these concentrations (not shown). Human cell-free hemoglobin was used for all experiments and was purified from healthy volunteers according to Institutional Review Boardapproved protocols as previously described (33) . Krebs-Henseleit (KH) buffer was used for all experiments and consisted of the following composition (final concentrations): 118.0 mM NaCl, 27.2 mM NaHCO 3, 4.8 mM KCl, 1 mM KH2PO4, 1.2 mM MgSO4, and 11.1 mM D-glucose with a pH of 7.4 at 37°C and 5% CO2 perfusion. Male Sprague-Dawley rats (200 -250 g) were purchased from Harlan (Indianapolis, IN).
Vessel bioassay experiments. For all vessel experiments, thoracic aortas from male Sprague-Dawley rats were used as previously described (10, 22) and according to Institutional Animal Care and Use Committee approval. Briefly, aortas were isolated and submerged in KH buffer maintained at room temperature. Vessels were cleansed of fat and connective tissue and segmented into 2-to 4-mm rings. Vessel rings were placed in vessel bioassay chambers (Radnoti Glass Technologies, Monrovia, CA) containing 15 ml KH buffer and perfused with a gas mixture composed of 21% O 2-5% CO2-74% N2 at 37°C (pH 7.45). A basal tension of 2 g was applied, and vessel rings were allowed to equilibrate for 1 h. Following equilibration, a hyperpolarizing dose of KCl (70 mM) was added to the baths to check for viability and assess maximum constriction.
To assess the effects of O2 on nitrite-or MNO-mediated vasodilation, vessels were equilibrated to 21%, 2%, 1%, or 0% O2 gas mixtures (containing 5% CO2 and balanced with N2). Gas was precisely delivered by mass flow controllers (Sierra Instruments) set to 0.15 l/min, a requirement found to be necessary to achieve reproducible hemoglobin fractional saturations between experiments. In all runs, vessels were pretreated with indomethacin (5 M) and N G -monomethyl-L-arginine (L-NMMA;100 M) to block cyclooxygenase and endothelial NO synthase, respectively. Vessels were preconstricted to ϳ50 -75% of maximal KCl constriction with L-phenylephrine (PE; 100 nM). Upon lowering O2 tensions, vessel tone can fluctuate before reaching a stable tone, as illustrated by Dalsgaard et al. (11) . For all experiments reported here, nitrite or MNO dose responses were initiated after a stable contractile tone had been reached. Nitrite-or MNO-dependent vasodilation was assessed by cumulative administration of increasing doses. Experiments were performed in the absence or presence of either human hemoglobin (20 M heme) or C-PTIO (200 M), which were added before the initiation of the nitrite or MNO dose response. Vasodilatory effects of cumulative MNO or nitrite additions were determined by measuring the change in tension and expressing this as the percent relaxation with respect to the maximal PE constriction. EC50 values were obtained by directly reading off the concentration (x-axis coordinate) at 50% relaxation on the dose-response curves.
The protocol employed above uses the same PE and L-NMMA concentrations at all O2 tensions resulting in lower stable contractile tensions (i.e., tension immediately before the initiation of the nitrite dose response) as the O2 tension is decreased (see RESULTS). To test if differing contractile tensions affect nitrite-dependent dilation and subsequent modulation by deoxyhemoglobin, a separate series of experiments was performed whereby upon deoxygenation with 0% O2, vessel tensions were increased by the addition of higher PE concentrations (0.5-1 M) and then nitrite was added as described above.
Hemoglobin fractional saturations. To assess hemoglobin fractional saturation at each O2 tension used, 1-ml aliquots from baths containing hemoglobin were taken in gas-tight syringes and injected into argon-purged sealed 1-ml cuvettes under a positive pressure of argon. Visible spectra (500 -700 nm) of hemoglobin were measured, and fractional saturation was determined by fitting against previously acquired base spectra (oxyhemoglobin, deoxyhemoglobin, and methemoglobin) using a least-squares method as previously described (20) .
Statistical analysis. Evaluation of the effects of either hemoglobin or C-PTIO on nitrite-or MNO-dependent vasodilation as a function of O 2 tension was assessed by two-way ANOVA with Bonferroni's post test. Evaluation of the effects of O2 tension on nitrite-or MNOdependent vasodilation was assessed by one-way ANOVA with Bonferonni's post test. Significance was set at P Յ 0.05, and analysis was performed using GraphPad Prism software (San Diego, CA).
RESULTS

Hemoglobin fractional saturation in vessel bioassay chambers.
To modulate hemoglobin fractional saturation in vessel bioassay chambers, previous studies have utilized a combination of different O 2 contents of the perfused gas together with coincubation with the negative allosteric effector inositol hexaphosphate (IHP) (8, 11, 28) . Although we have not previously observed basal effects of IHP on vessel tone, other investigators have suggested such a confounding effect (11, 28) . To exclude potential artifacts arising from the use of IHP, we decided to first determine the conditions required to achieve hemoglobin fractional saturations spanning 0 -1 (i.e., deoxy Ϫ oxy) without the addition of exogenous allosteric effectors by testing a variety of gases comprising different O 2 tensions together with different perfusion rates [since most vessel bioassay chambers are open systems, the actual concentration of dissolved O 2 will vary depending on many factors, including the O 2 content of the gas, perfusion pressure, flow rate, or atmospheric pressure, to name but a few (22)]. Moreover, the sensitivity of hemoglobin fractional saturation to small changes in O 2 tension around the hemoglobin P 50 , coupled with the potential variability in P 50 of different cell-free hemoglobin preparations, necessitate a direct measurement of fractional saturations. Figure 1A shows representative visible spectra of hemoglobin; Fig. 1B shows the calculated fractional saturations when baths in our experimental setup were perfused with a constant flow rate (0.15 l/min) of gases composed of 21%, 2%, 1%, and 0% O 2 , which resulted in fractional saturations of 0.97, 0.66, 0.26, and 0.04, respectively. We suggest that such measurements are vitally important in studies that attempt to evaluate the functional consequences of the allosteric regulation of hemoglobin's nitrite reductase activity.
Hemoglobin-dependent inhibition of nitrite-mediated vasodilation is regulated by fractional saturation. Figure 2A shows nitrite-dependent vasodilation in the absence and presence of hemoglobin at 21% or 0% O 2 (traces for 2% or 1% are not shown for the sake of clarity), and Fig. 2B shows EC 50 values at each O 2 tension in the presence or absence of hemoglobin. Similar to recent data by Dalsgaard et al. (11) , nitrite stimulated dilation of rat thoracic aortas in a process that was more efficient as the O 2 tension was lowered. We recognize that this represents a surprising potency of nitrite, the mechanism for which remains unclear and which could include interactions with smooth muscle deoxyheme proteins including deoxymyoglobin (36, 41) . We chose to focus on how hemoglobin, and specifically how hemoglobin O 2 fractional saturation, regulates nitrite-dependent vasodilation. We found that hemoglobin significantly inhibited nitrite-dependent relaxation (indicated by an increase in EC 50 ) at 21% and 2% but not at 1% or 0% O 2 , underscoring a key difference between oxyhemoglobin and deoxyhemoglobin interactions with nitrite in the aortic ring system. We note that Dalsgaard et al. (11) observed the same phenomenon, which they ascribed to a strange artifact of IHP alone rather than an effect of IHP on promoting hemoglobin deoxygentation. Importantly, we saw the same effect with simple hemoglobin deoxygenation in the absence of IHP. Another possibility is that oxyhemoglobin scavenges nitrite faster compared with deoxyhemoglobin, a prediction not expected based on reaction kinetics at these nitrite and hemoglobin concentrations (19) . To test this, we measured methemoglobin (by spectral deconvolution), a product of both deoxyhemoglobin and oxyhemoglobin reactions with nitrite, before and after nitrite dose-response curves had been completed. Methemoglobin was undetectable prior to the addition of nitrite and did not increase beyond 0.1 M at all O 2 tensions (data not shown). We next tested whether this interaction between nitrite and deoxyhemoglobin was related to differential NO scavenging effects of deoxyhemoglobin versus oxyhemoglobin (again not expected based on kinetic considerations). tensions. Vessel bioassay baths containing hemoglobin were perfused with gas mixtures composed of either 21%, 2%, 1%, or 0% O2 (with 5% CO2 and balanced with N2). A: representative spectra of hemoglobin at each O2 tension. , wavelength. B: calculated fractional saturations after spectral deconvolution. Data shown means Ϯ SE; n ϭ 3-5.
Hemoglobin-dependent inhibition of NO-mediated vasodilation is not affected by O 2 fractional saturation.
Unlike nitrite, a trend toward increasing EC 50 values for NO-dependent dilation was observed with lowering O 2 tensions, which was significant at 0% O 2 . Most importantly, in sharp contrast to nitrite-dependent vasodilation, hemoglobin inhibited NO-dependent vasodilation to similar extents at all fractional O 2 saturations. This suggests that nitrite, compared with an authentic NO donor, displays a unique interaction with deoxyhemoglobin that promotes vasodilation. Finally, and as an additional control, we evaluated the O 2 dependence of dilation stimulated by forskolin, a cAMP-dependent vasodilator, and found that lowering O 2 tensions increased EC 50 values from 306 Ϯ 16.4 to 749.8 Ϯ 134 nM (P ϭ 0.01, n ϭ 5) as the O 2 tension was lowered from 21% to 0%. This is opposite to nitrite-dependent effects, and collectively these data underlie the sensitivity for enhanced nitrite-dependent dilation during hypoxia.
Contractile tension does not affect nitrite-dependent dilation at low O 2 tensions.
Exposure of vessels to low O 2 tensions decreases stable PE-induced contractile tone. For example, in the experiments shown in Fig. 2 , using a constant PE (100 nM) concentration at each O 2 tension, stable contractile tensions were 1.7 Ϯ 0.1, 1.14 Ϯ 0.06, 0.98 Ϯ 0.07, and 0.53 Ϯ 0.04 g at 21%, 2%, 1%, and 0% O 2 , respectively (data are means Ϯ SE; n ϭ 15-25). This may affect the potency of nitritedependent dilation at different O 2 tensions and, therefore, hemoglobin-dependent modulation also. To test this, the contractile tension at 0% O 2 was increased by the addition of more PE. Under these constant contractile tension experiments, nitrite was still a more potent vasodilator compared with 21% O 2 , as indicated by lower EC 50 values, with this increased potency not being significantly different to when a constant PE concentration was used (Fig. 3A) . Figure 3B shows that with the use of the constant contractile tone protocol, deoxyhemoglobin still did not significantly inhibit nitrite-dependent dilation. We note that the EC 50 value for nitrite-dependent dilation at 21% O 2 in Fig. 3 was lower than those reported in Fig. 2 and attribute this interexperimental variance to intrinsic variables associated with different batches of animals used to obtain Repeated two-way ANOVA analysis indicated a significant (P ϭ Ͻ 0.05) right shift of nitrite-dependent dilation at 21% O2 by hemoglobin. *P Յ 0.001 relative to corresponding the nitrite dose in the absence of hemoglobin at 21% O2 by Bonferroni's post test. At 0% O2, repeated two-way ANOVA analysis showed no significant effect (P ϭ 0.93) of hemoglobin on nitrite dose-dependent dilation. B: EC50 values for nitrite-dependent vasodilation at 21%, 2%, 1%, and 0% O2 in the absence and presence of hemoglobin. Hemoglobin inhibited nitrite-dependent relaxation at 21% and 2% O2 but not at 1% or 0% O2. Data are means Ϯ SE; n ϭ 4 -7. Data were analyzed by two-way ANOVA with Bonferroni's post test to evaluate significant differences between control and hemoglobin at each O2 tension. P values are as shown. One-way ANOVA indicated that decreasing O2 tension increases the potency of nitrite-mediated dilation (in the absence of hemoglobin). *P Ͻ 0.001 relative to nitrite at 21%O2. C and D: data in a similar format to those in A and B except that methylamine hexamethylene methylamine NONOate (Mahma/NO)-dependent vasodilation was tested. For C, repeated two-way ANOVA analysis indicated significant right shifts of nitrite-dependent dilation at 21% and 0% O2 by hemoglobin (P ϭ 0.0003 and P ϭ 0.005 for 21% and 0% O2, respectively). *P Յ 0.001 and #P Յ 0.001 relative to corresponding the nitrite dose in the absence of hemoglobin at 21% and 0% O2, respectively, by Bonferroni's post test. For D, P values indicate differences between EC50 values in the presence and absence of hemoglobin at each respective O2 tension by two-way ANOVA with Bonferroni's post test. Effects of O2 on NO dilation (in the absence of hemoglobin) were assessed by one-way ANOVA with Bonferroni's posttest. *P Յ 0.001 relative to 21% O2. Data in C and D were obtained from 2-6 separate experiments and indicate that hemoglobin inhibits NO-dependent vasodilation at all fractional saturations. aortic segments. Importantly, in both Figs. 2 and 3, hypoxia significantly decreases the EC 50 for nitrite-dependent vasodilation.
Comparison of C-PTIO and hemoglobin on nitrite-dependent vasodilation at low O 2 tensions. Finally, we evaluated the effects of C-PTIO, a cell-impermeable non-heme-based NO scavenger, on nitrite-dependent dilation. Figure 4 shows the fold change in the EC 50 for nitrite-dependent dilation at 21% and 0% O 2 in the presence of either hemoglobin or C-PTIO. Both C-PTIO and hemoglobin inhibited nitrite-dependent vasodilation, i.e., increased the EC 50 , at 21% O 2 between threeand fourfold. However, at 0% O 2 , only C-PTIO inhibited nitrite-dependent dilation, whereas hemoglobin had no effect [absolute EC 50 values at 0% O 2 were 6.4 Ϯ 1.2, 19.1 Ϯ 4.9, and 6.6 Ϯ 0.7 M (means Ϯ SE; n ϭ 3-7) for nitrite alone, nitrite ϩ C-PTIO, and nitrite ϩ deoxyhemoglobin, respectively]. These data suggest that the unique interaction between nitrite and deoxyhemoglobin cannot be explained by differential NO scavenging at different O 2 partial pressures.
DISCUSSION
Nitrite is generally considered an inert end product of NO metabolism. However, the recent appreciation that hypoxia regulates nitrite biology and the advent of methods sensitive enough to measure nitrite in biological matrixes have led to multiple studies strongly supporting a role for circulating nitrite in mediating NO-dependent signaling in the vasculature (6, 8, 27, 29, 31, 35, 38, 44) . For example, nitrite protects against tissue injury in a variety of ischemic diseases (liver and heart ischemia-reperfusion injury, hypoxic pulmonary vasoconstriction, and hemorrhagic stroke) via NO-dependent mechanisms (13, 21, 23, 34, 43, 45) . Moreover, nitrite also has effects under conditions not characterized by ischemia per se but by the loss of endogenous NO bioactivity. Examples include nitrite transducing extrapulmonary effects of inhaled NO therapy and nitrite-dependent effects on blood pressure (3, 7, 26) . In addition, recent insights have indicated that circulating nitrite is a predictor of exercise capacity, and arterialvenous gradients in nitrite have suggested a consumptive pathway across the microcirculation that is associated with increased blood flow (18, 37) . Potential mechanisms for nitrite bioconversion into NO and other NO-containing species include reactions with deoxyheme proteins or xanthine oxidase under ischemic conditions (17) .
Although mechanisms that convert nitrite to NO in the vascular compartment remain under investigation, a viable mechanism that couples O 2 sensing (and hence hypoxia) with nitrite reduction at physiological pH is reactions with hemoglobin (8, 9, 31) . Key data that support this model were obtained using relaxation of isolated aortic vessels as a functional readout for NO signaling (8, 9) . We observed previously values of nitrite-dependent dilation at 21% or 0% O2. For the 0% O2 condition, vessels were treated with either a constant dose of L-phenylephrine (PE) or higher doses of PE to achieve a vessel tension similar to the contractile tension at 21% O2. Shown are average data from 3 separate experiments in which for the constant PE condition, vessel tension ranged from 35% to 49% of tension at 21% O2, whereas with the higher PE condition, vessel tension ranged from 62% to 98% of tension at 21% O2. No significant differences in EC50 values were observed using either protocol. Data are means Ϯ SE. P value were determined by t-test (n ϭ 3). B: nitrite-dependent dilation at 0% O2 in the absence or presence of hemoglobin using vessels where the contractile tone was increased to 98% of the contractile tension at 21% O2. No significant differences (P ϭ 0.22) between nitrite dose-dependent dilation in the absence or presence of hemoglobin were observed by repeated-measures two-way ANOVA.
that deoxygenated, but not oxygenated, red blood cells potentiate nitrite-dependent vasodilation in a NO-dependent manner. More recently, Dalsgaard et al. (11) reported that using cellfree hemoglobin, oxyhemoglobin inhibits, whereas deoxyhemoglobin potentiated, nitrite-dependent vasodilation, but the effect of the latter was attributed to the presence of the allosteric effector IHP. In addition, the authors concluded that the lack of an inhibition on nitrite-dependent vasodilation by deoxyhemoglobin may be due to higher reaction rates between nitrite and oxyhemoglobin versus nitrite and deoxyhemoglobin. However, considering that nitrite-dependent dilation proceeded via NO (indicated by a role for sGC) and that hemoglobin reactions with NO are significantly (Ͼ6 orders of magnitude) faster compared with those with nitrite, we reasoned that the major effect of oxyhemoglobin and deoxyhemoglobin with respect to inhibition of vasodilation in this reaction system would be NO and not nitrite scavenging.
To test these concepts, we first standardized our experimental system. Perfusion of bioassay chambers with gases composed of different O 2 tensions at a fixed flow rate resulted in systematic alteration of the hemoglobin fractional saturation that encompassed the oxyhemoglobin to deoxygenated conformations without the use of exogenous allosteric mediators. The effects of hemoglobin fractional saturation on both nitrite-and NO-dependent (using MNO) vasodilation were then tested. Figure 2 , C and D, shows that at all fractional saturations, hemoglobin inhibited NO-dependent vasodilation, consistent with the rapid reaction of either oxyhemoglobin or deoxyhemoglobin with NO (reactions [3] [4] . This confirmed that under these experimental conditions, both oxyhemoglobin and deoxyhemoglobin were competent to react and inhibit NO signaling. Similar to NO, oxyhemoglobin inhibited nitritedependent vasodilation (Fig. 2B) . Unlike NO, however, as hemoglobin was deoxygenated, the potency of inhibition was decreased with no significant inhibition being observed at hemoglobin fractional saturations of 0.26 or 0.04. These data may be explained by either 1) slower rates of nitrite scavenging by deoxyhemoglobin over oxyhemoglobin, 2) transition of nitrite-dependent dilation from an NO-dependent to NO-independent mechanism as O 2 tensions are decreased, or 3) the presence of both vasoconstrictive (NO scavenging) and vasodilatory (NO formation) activities for deoxyhemoglobin.
The first is unlikely to play a significant role on the basis that both oxyhemoglobin and deoxyhemoglobin react with nitrite slowly such that over the time scale of vasodilation responses (Ͻ5 min/dose) relatively little nitrite will be scavenged. Note that the nitrite reaction with oxyhemoglobin under these conditions proceeds in the lag or slow phase and is therefore slower than the reaction of nitrite with deoxyhemoglobin (19) . Indeed, assessment of hemoglobin oxidation and ligation state indicated that throughout the course of our experiments, Ͼ95% of the hemoglobin remained in the oxy or deoxy conformation, suggesting little direct scavenging of nitrite (not shown). These results also indicate that the hemoglobin was in a form competent to rapidly scavenge NO. To probe the second option, the effects of C-PTIO, an NO scavenger that unlike hemoglobin does not react with nitrite, was tested. C-PTIO inhibited nitritedependent vasodilation at both 21% and 0% O 2 (Fig. 4) . These data indicate that nitrite dilates vessels via NO at all O 2 tensions and predicts, therefore, that deoxyhemoglobin should also scavenge the formed NO and inhibit vasodilation. The fact that the latter was not observed (Fig. 2B) suggests the third possibility: in the presence of deoxyhemoglobin, nitrite-dependent bioactivity is a consequence of a net effect of vasoconstriction (NO scavenging) and vasodilation (NO formation). This is best experimentally defined by a highly significant interaction between hemoglobin deoxygenation (by low O 2 in our study or the use of IHP in the study of Dalsgaard et al.) and nitrite. Two-way ANOVA evaluating hemoglobin and O 2 fractional saturation on nitrite-dependent vasodilation can be used to test the significance of this interaction. We note that we fully reproduce the experiments of Dalsgaard et al., but we can now clarify that there was a significant nitrite reductase activity of deoxyhemoglobin in their experiments that was not appreciated.
It remains unclear how these dual reactivities of deoxyhemoglobin are regulated, although recent suggestions have included a possible role for intermediate reactive nitrogen species including N 2 O 3 (15, 20, 39) . We also cannot test the more relevant question of high hematocrits present in vivo. In this circumstance, it is possible that the nitrite reduction to NO occurs in specific compartments within the erythrocyte submembrane that promote these reactions. Such physiological considerations have been recently reviewed (16) .
In previous studies, we and others (9, 20) have shown that the initial rate of nitrite reduction by hemoglobin follows a bell-shaped dependency with respect to hemoglobin fractional saturation that reaches a maximum around the hemoglobin P 50 . At the P 50 , an optimal balance of deoxyheme substrate availability and rate constant result in maximal nitrite reduction kinetics (20, 40) . Based on these kinetic observations, one would predict to see a maximal dilation by nitrite at hemoglobin fractional saturations close to the P 50 . However, vasodilation experiments assess the magnitude of relaxation and not the kinetics. In other words, the vasodilation experiments performed here reflect the capacity for a given dose of nitrite to stimulate vasodilation but not the rate at which this occurs.
Our study was focused on elucidating interactions between O 2 , hemoglobin, and nitrite bioactivity. Similar to Dalsgaard et al. (11), we noted a significant potentiation of nitrite dilation of aortic vessels at low O 2 tensions. The mechanisms intrinsic to the vessel wall that regulated this hypoxic reactivity are not known but ultimately feed into NO-dependent activation of sGC pathways. Whether hypoxia will potentiate nitrite reactivity in resistance vessels remains to be studied, which is an important consideration since large vessels like the aorta are not typically exposed to low O 2 tensions.
Our data also suggest that nitrite may be an adjunct therapy for attenuating the vasoconstrictive effects associated with the use of cell-free hemoglobin-based blood substitutes. The latter constitutes a variety of hemoglobins whereby the oxygen binding and structural properties have been modified to improve circulatory lifetimes and O 2 delivery and limit nephrotoxicity (1, 32) . In addition to these structural modifications and in the context of this report, we propose that the coadministration of nitrite with hemoglobin-based substitutes may promote or at the very least preserve NO signaling in the vasculature. Moreover, our present and recent data underscore the novel concept that designing cell-free hemoglobins that possess more efficient nitrite reductase activity may provide more efficacious resuscitation formulations that improve blood flow by coupling O 2 sensing to local NO production.
In summary, this study sheds insights into how hemoglobin fractional saturation critically regulates nitrite-dependent NO formation and subsequent vasodilation and further support the concept that vascular functions of nitrite may be controlled by hemoglobin fractional saturation both endogenously and during therapeutic applications.
